Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15704140rdf:typepubmed:Citationlld:pubmed
pubmed-article:15704140lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:15704140lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15704140lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:15704140lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:15704140lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:15704140pubmed:issue4lld:pubmed
pubmed-article:15704140pubmed:dateCreated2005-4-25lld:pubmed
pubmed-article:15704140pubmed:abstractTextLAF-4, which encodes a nuclear protein with transactivation potential, is fused to the MLL gene in acute lymphoblastic leukemia (ALL). We identified LAF-4 as a gene that is transcriptionally deregulated in breast tumors and thus may have a pathological role in mammary tumorigenesis. In line with the previous finding that LAF-4 expression is tissue specific, we did not detect any LAF-4 mRNA in normal mammary epithelial cell lines. However, 2 of 5 breast cancer cell lines were found to express LAF-4 at both the RNA and protein levels. In 2 of 9 primary tumor-normal pairs, the expression of LAF-4 was clearly elevated in the tumor tissue. Using RNA in situ hybridization, we demonstrated that LAF-4 is expressed in mammary tumor cells but not in normal acini. In a group of 64 primary human breast tumors, we found that LAF-4 was overexpressed in approximately 20% of the cases. Although epigenetic changes may be involved in altered expression of some genes, differences in LAF-4 expression were not associated with DNA methylation of the predicted promoter region. Our results suggest that LAF-4 may be a proto-oncogene that is transcriptionally activated in some cases of breast cancer.lld:pubmed
pubmed-article:15704140pubmed:languageenglld:pubmed
pubmed-article:15704140pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15704140pubmed:citationSubsetIMlld:pubmed
pubmed-article:15704140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15704140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15704140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15704140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15704140pubmed:statusMEDLINElld:pubmed
pubmed-article:15704140pubmed:monthJullld:pubmed
pubmed-article:15704140pubmed:issn0020-7136lld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:AndrulisIrene...lld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:GokgozNalanNlld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:PinnaduwageDu...lld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:ToMinh DMDlld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:FaserukStepha...lld:pubmed
pubmed-article:15704140pubmed:authorpubmed-author:DoneSusan JSJlld:pubmed
pubmed-article:15704140pubmed:copyrightInfoCopyright 2005 Wiley-Liss, Inc.lld:pubmed
pubmed-article:15704140pubmed:issnTypePrintlld:pubmed
pubmed-article:15704140pubmed:day1lld:pubmed
pubmed-article:15704140pubmed:volume115lld:pubmed
pubmed-article:15704140pubmed:ownerNLMlld:pubmed
pubmed-article:15704140pubmed:authorsCompleteYlld:pubmed
pubmed-article:15704140pubmed:pagination568-74lld:pubmed
pubmed-article:15704140pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:meshHeadingpubmed-meshheading:15704140...lld:pubmed
pubmed-article:15704140pubmed:year2005lld:pubmed
pubmed-article:15704140pubmed:articleTitleLAF-4 is aberrantly expressed in human breast cancer.lld:pubmed
pubmed-article:15704140pubmed:affiliationFred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.lld:pubmed
pubmed-article:15704140pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15704140pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:15704140pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3899entrezgene:pubmedpubmed-article:15704140lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15704140lld:entrezgene
lhgdn:association:50323lhgdn:found_inpubmed-article:15704140lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15704140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15704140lld:pubmed